{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T06:09:36Z","timestamp":1772604576258,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.jns.2008.04.030","type":"journal-article","created":{"date-parts":[[2008,6,11]],"date-time":"2008-06-11T09:26:52Z","timestamp":1213176412000},"page":"191-202","source":"Crossref","is-referenced-by-count":27,"title":["Bowman\u2013Birk inhibitor suppresses autoimmune inflammation and neuronal loss in a mouse model of multiple sclerosis"],"prefix":"10.1016","volume":"271","author":[{"given":"Tarik","family":"Touil","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bogoljub","family":"Ciric","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elvira","family":"Ventura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth S.","family":"Shindler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruno","family":"Gran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdolmohamad","family":"Rostami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jns.2008.04.030_bib1","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","article-title":"Multiple sclerosis \u2014 the plaque and its pathogenesis","volume":"354","author":"Frohman","year":"2006","journal-title":"N Engl J Med"},{"issue":"11 Suppl 5","key":"10.1016\/j.jns.2008.04.030_bib2","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1212\/WNL.63.11_suppl_5.S35","article-title":"Strategies for managing the side effects of treatments for multiple sclerosis","volume":"63","author":"Langer-Gould","year":"2004","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.jns.2008.04.030_bib3","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/WCO.0b013e328122de1b","article-title":"Combination therapies for multiple sclerosis: scientific rationale, clinical trials, and clinical practice","volume":"20","author":"Costello","year":"2007","journal-title":"Curr Opin Neurol"},{"issue":"1","key":"10.1016\/j.jns.2008.04.030_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/ana.20913","article-title":"How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis","volume":"60","author":"Steinman","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jns.2008.04.030_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3109\/10408369509084683","article-title":"Immunological aspects of experimental allergic encephalomyelitis and multiple sclerosis","volume":"32","author":"Martin","year":"1995","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.04.030_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0165-5728(98)00241-0","article-title":"Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system","volume":"94","author":"Cuzner","year":"1999","journal-title":"J Neuroimmunol"},{"issue":"9","key":"10.1016\/j.jns.2008.04.030_bib7","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.4049\/jimmunol.178.9.5871","article-title":"Neutrophil elastase up-regulates cathepsin B and matrix metalloprotease-2 expression","volume":"178","author":"Geraghty","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.jns.2008.04.030_bib8","doi-asserted-by":"crossref","first-page":"5690","DOI":"10.4049\/jimmunol.170.11.5690","article-title":"Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2","volume":"70","author":"Uehara","year":"2003","journal-title":"J Immunol"},{"issue":"7","key":"10.1016\/j.jns.2008.04.030_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nri1841","article-title":"Neutrophil serine proteases: specific regulators of inflammation","volume":"6","author":"Pham","year":"2006","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"10.1016\/j.jns.2008.04.030_bib10","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1084\/jem.20051342","article-title":"Dystroglycan is selectively cleaved at the parenchymal basement membrane at sites of leukocyte extravasation in experimental autoimmune encephalomyelitis","volume":"203","author":"Agrawal","year":"2006","journal-title":"J Exp Med"},{"issue":"3","key":"10.1016\/j.jns.2008.04.030_bib11","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/glia.10108","article-title":"Matrix metalloproteinases in neuroinflammation","volume":"39","author":"Rosenberg","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.jns.2008.04.030_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1432-1327.1998.2580037.x","article-title":"Human matrix metalloproteinase-9: activation by limited trypsin treatment and generation of monoclonal antibodies specific for the activated form","volume":"258","author":"Duncan","year":"1998","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jns.2008.04.030_bib13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/0304-3940(95)12173-0","article-title":"Matrix metalloproteinases degrade myelin basic protein","volume":"201","author":"Chandler","year":"1995","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jns.2008.04.030_bib14","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/jnr.490360409","article-title":"Gelatinase B is present in the cerebrospinal fluid during experimental autoimmune encephalomyelitis and cleaves myelin basic protein","volume":"36","author":"Gijbels","year":"1993","journal-title":"J Neurosci Res"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.04.030_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jns.2006.11.021","article-title":"Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators","volume":"259","author":"Yong","year":"2007","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.jns.2008.04.030_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1212\/WNL.53.1.20","article-title":"Matrix metalloproteinases in inflammatory demyelination: targets for treatment","volume":"53","author":"Kieseier","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2008.04.030_bib17","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1365-2990.1997.tb01315.x","article-title":"Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke","volume":"23","author":"Anthony","year":"1997","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.1016\/j.jns.2008.04.030_bib18","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/brain\/awg285","article-title":"Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis","volume":"126","author":"Bar-Or","year":"2003","journal-title":"Brain"},{"key":"10.1016\/j.jns.2008.04.030_bib19","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0165-5728(92)90192-N","article-title":"Gelatinase in the cerebrospinal fluid of patients with multiple sclerosis and other inflammatory neurological disorders","volume":"41","author":"Gijbels","year":"1992","journal-title":"J Neuroimmunol"},{"issue":"Pt 2","key":"10.1016\/j.jns.2008.04.030_bib20","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/brain\/122.2.191","article-title":"Serum gelatinase B, TIMP-1 and TIMP-2 levels in multiple sclerosis. A longitudinal clinical and MRI study","volume":"122","author":"Lee","year":"1999","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.jns.2008.04.030_bib21","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1399-3011.1985.tb02155.x","article-title":"The Bowman\u2013Birk inhibitor. Trypsin- and chymotrypsin-inhibitor from soybeans","volume":"25","author":"Birk","year":"1985","journal-title":"Int J Pept Protein Res"},{"key":"10.1016\/j.jns.2008.04.030_bib22","first-page":"1437","article-title":"Inhibition of cathepsin G and human granulocyte elastase by multiple forms of Bowman\u2013Birk type soybean inhibitor (translated from Russian)","volume":"58","author":"Larionova","year":"1993","journal-title":"Biokhimiia"},{"key":"10.1016\/j.jns.2008.04.030_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/abbi.1997.0182","article-title":"Soybean Bowman\u2013Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase","volume":"344","author":"Ware","year":"1997","journal-title":"Arch Biochem Biophys"},{"issue":"6 Suppl","key":"10.1016\/j.jns.2008.04.030_bib24","doi-asserted-by":"crossref","first-page":"1406S","DOI":"10.1093\/ajcn\/68.6.1406S","article-title":"The Bowman\u2013Birk inhibitor from soybeans as an anticarcinogenic agent","volume":"68","author":"Kennedy","year":"1998","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"10.1016\/j.jns.2008.04.030_bib25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/01635589209514216","article-title":"Humoral and cellular immune functions are not compromised by the anticarcinogenic Bowman\u2013Birk inhibitor","volume":"18","author":"Maki","year":"1992","journal-title":"Nutr Cancer"},{"issue":"3","key":"10.1016\/j.jns.2008.04.030_bib26","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0304-3835(92)90095-D","article-title":"Distribution of the Bowman Birk protease inhibitor in mice following oral administration","volume":"62","author":"Billings","year":"1992","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jns.2008.04.030_bib27","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/01635589309514259","article-title":"Preparation and production of a cancer chemopreventive agent, Bowman\u2013Birk inhibitor concentrate","volume":"19","author":"Kennedy","year":"1993","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.jns.2008.04.030_bib28","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1749-6632.2001.tb02732.x","article-title":"Development of Bowman\u2013Birk inhibitor for chemoprevention of oral head and neck cancer","volume":"952","author":"Meyskens","year":"2001","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"10.1016\/j.jns.2008.04.030_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/pros.1077","article-title":"Effects of Bowman\u2013Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia","volume":"48","author":"Malkowicz","year":"2001","journal-title":"Prostate"},{"issue":"12","key":"10.1016\/j.jns.2008.04.030_bib30","first-page":"4684","article-title":"Clinical modulation of oral leukoplakia and protease activity by Bowman\u2013Birk inhibitor concentrate in a phase IIa chemoprevention trial","volume":"6","author":"Armstrong","year":"2000","journal-title":"Clin Cancer Res"},{"issue":"6","key":"10.1016\/j.jns.2008.04.030_bib31","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1177\/1352458506070769","article-title":"The protease inhibitor, Bowman\u2013Birk Inhibitor, suppresses experimental autoimmune encephalomyelitis: a potential oral therapy for multiple sclerosis","volume":"12","author":"Gran","year":"2006","journal-title":"Mult Scler"},{"key":"10.1016\/j.jns.2008.04.030_bib32","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2004.07.019","article-title":"Early administration of IL-12 suppresses EAE through induction of interferon-gamma","volume":"156","author":"Gran","year":"2004","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.jns.2008.04.030_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0167-5699(99)01512-1","article-title":"Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes","volume":"21","author":"Aloisi","year":"2000","journal-title":"Immunol Today"},{"key":"10.1016\/j.jns.2008.04.030_bib34","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.4049\/jimmunol.166.4.2717","article-title":"Brain dendritic cells and macrophages\/microglia in central nervous system inflammation","volume":"166","author":"Fischer","year":"2001","journal-title":"J Immunol"},{"issue":"5","key":"10.1016\/j.jns.2008.04.030_bib35","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1177\/1352458506070629","article-title":"Retinal ganglion cell loss induced by acute optic neuritis in a relapsing model of multiple sclerosis","volume":"12","author":"Shindler","year":"2006","journal-title":"Mult Scler"},{"issue":"2","key":"10.1016\/j.jns.2008.04.030_bib36","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1080\/01635589409514343","article-title":"Studies related to the potential antigenicity of the Bowman\u2013Birk inhibitor, an anticarcinogenic protease inhibitor isolated from soybeans","volume":"22","author":"Maki","year":"1994","journal-title":"Nutr Cancer"},{"issue":"7","key":"10.1016\/j.jns.2008.04.030_bib37","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/carcin\/bgi062","article-title":"Bowman\u2013Birk inhibitor abates proteasome function and suppresses the proliferation of MCF7 breast cancer cells through accumulation of MAP kinase phosphatase-1","volume":"26","author":"Chen","year":"2005","journal-title":"Carcinogenesis"},{"issue":"11","key":"10.1016\/j.jns.2008.04.030_bib38","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.4049\/jimmunol.160.11.5262","article-title":"Generation of an MHC class II-restricted T cell epitope by extracellular processing of hepatitis delta antigen","volume":"160","author":"Accapezzato","year":"1998","journal-title":"J Immunol"},{"issue":"10","key":"10.1016\/j.jns.2008.04.030_bib39","doi-asserted-by":"crossref","first-page":"9291","DOI":"10.1074\/jbc.M410396200","article-title":"A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2","volume":"280","author":"Tchougounova","year":"2005","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.jns.2008.04.030_bib40","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1189\/jlb.0203086","article-title":"Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate","volume":"74","author":"Pezzato","year":"2003","journal-title":"J Leukoc Biol"},{"issue":"30","key":"10.1016\/j.jns.2008.04.030_bib41","doi-asserted-by":"crossref","first-page":"27319","DOI":"10.1074\/jbc.M202842200","article-title":"Tumor necrosis factor-alpha-induced proteolytic activation of pro-matrix metalloproteinase-9 by human skin is controlled by down-regulating tissue inhibitor of metalloproteinase-1 and mediated by tissue-associated chymotrypsin-like proteinase","volume":"277","author":"Han","year":"2002","journal-title":"J Biol Chem"},{"issue":"5","key":"10.1016\/j.jns.2008.04.030_bib42","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0753-3322(02)00196-8","article-title":"Regulation of elastase-type endopeptidase activity, MMP-2 and MMP-9 expression and activation in human dermal fibroblasts by fucose and a fucose-rich polysaccharide","volume":"56","author":"Isnard","year":"2002","journal-title":"Biomed Pharmacother"},{"issue":"15","key":"10.1016\/j.jns.2008.04.030_bib43","doi-asserted-by":"crossref","first-page":"4730","DOI":"10.1021\/jf034576u","article-title":"In vitro inhibition of the activation of Pro-matrix Metalloproteinase 1(Pro-MMP-1) and Pro-matrix metalloproteinase 9 (Pro-MMP-9) by rice and soybean Bowman\u2013Birk inhibitors","volume":"52","author":"Bawadi","year":"2004","journal-title":"J Agric Food Chem"},{"issue":"11","key":"10.1016\/j.jns.2008.04.030_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1023\/B:bile.0000025900.33812.7c","article-title":"Inhibition of matrix metalloproteinase-1 activity by the soybean Bowman\u2013Birk inhibitor","volume":"26","author":"Losso","year":"2004","journal-title":"Biotechnol Lett"},{"issue":"11","key":"10.1016\/j.jns.2008.04.030_bib45","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/intimm\/dxg127","article-title":"IL-5-deficient mice are susceptible to experimental autoimmune encephalomyelitis","volume":"15","author":"Weir","year":"2003","journal-title":"Int Immunol"},{"issue":"6","key":"10.1016\/j.jns.2008.04.030_bib46","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1002\/eji.1830240629","article-title":"Interleukin-10 prevents experimental allergic encephalomyelitis in rats","volume":"24","author":"Rott","year":"1994","journal-title":"Eur J Immunol"},{"issue":"7","key":"10.1016\/j.jns.2008.04.030_bib47","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.4049\/jimmunol.161.7.3299","article-title":"IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice","volume":"161","author":"Bettelli","year":"1998","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.jns.2008.04.030_bib48","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1084\/jem.189.6.1005","article-title":"Transgenic interleukin 10 prevents induction of experimental autoimmune encephalomyelitis","volume":"189","author":"Cua","year":"1999","journal-title":"J Exp Med"},{"issue":"11","key":"10.1016\/j.jns.2008.04.030_bib49","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.4049\/jimmunol.163.11.6338","article-title":"Activation of regulatory cells suppresses experimental allergic encephalomyelitis via secretion of IL-10","volume":"163","author":"Stohlman","year":"1999","journal-title":"J Immunol"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.04.030_bib50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jneuroim.2006.04.009","article-title":"Exogenous IL-12 suppresses experimental autoimmune encephalomyelitis (EAE) by tuning IL-10 and IL-5 levels in an IFN-gamma-dependent way","volume":"176","author":"Berghmans","year":"2006","journal-title":"J Neuroimmunol"},{"issue":"11","key":"10.1016\/j.jns.2008.04.030_bib51","doi-asserted-by":"crossref","first-page":"7202","DOI":"10.4049\/jimmunol.175.11.7202","article-title":"Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response","volume":"175","author":"Zhang","year":"2005","journal-title":"J Immunol"},{"issue":"6911","key":"10.1016\/j.jns.2008.04.030_bib52","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nature01158","article-title":"The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease","volume":"420","author":"Youssef","year":"2002","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.jns.2008.04.030_bib53","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neuron.2006.09.011","article-title":"The neurobiology of multiple sclerosis: genes, inflammation, and neurodegeneration","volume":"52","author":"Hauser","year":"2006","journal-title":"Neuron"},{"issue":"1\u20132","key":"10.1016\/j.jns.2008.04.030_bib54","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jneuroim.2006.11.025","article-title":"Neurodegeneration and -protection in autoimmune CNS inflammation","volume":"184","author":"Diem","year":"2007","journal-title":"J Neuroimmunol"}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08002037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X08002037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T19:43:46Z","timestamp":1684439026000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X08002037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":54,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0022510X08002037"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2008.04.030","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}